Serogroup B Meningococcal Disease Vaccine Recommendations at a University, New Jersey, USA, 2016

Abstract

In response to a university-based serogroup B meningococcal disease outbreak, the serogroup B meningococcal vaccine Trumenba was recommended for students, a rare instance in which a specific vaccine brand was recommended. This outbreak highlights the challenges of using molecular and immunologic data to inform real-time response.

Keywords

• meningococcal meningitis
• serogroup B
• universities
• meningococcal vaccines
• molecular diagnostic techniques
• vaccination recommendations